Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation

November 9, 2026 updated by: Pengxu Wei, National Research Center for Rehabilitation Technical Aids

Developing Clinic-oriented Quantitative Effectiveness Evaluation and Individualized Therapeutic Programs of Rehabilitation

Using robotics, sensors, and sEMG to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Study Overview

Status

Recruiting

Detailed Description

Using robotics, sensors, sEMG or other methods to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Beijing, China, 100176
        • Recruiting
        • National Research Center for Rehabilitation Technical Aids
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Recruiting with advertising

Description

Inclusion Criteria (for healthy people):

  • no history of psychological/psychotic problems, no history of important diseases.

Exclusion Criteria (for healthy people):

  • history of psychological/psychotic problems

Inclusion Criteria (for patients with motor deficits or dysphagia):

  • patients with motor function impairment such as post stroke hemiplegia.

Exclusion Criteria (for patients with motor deficits or dysphagia):

  • cognitively or physically unable to cooperate with the examiner to finish the test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Heahlthy people

perform motor function assessment by using scales, sEMG, and inertia sensors

perform motor function assessment by using scales, sEMG, and inertia sensors

People with motor deficits

perform motor function assessment by using scales, sEMG, and inertia sensors

perform motor function assessment by using scales, sEMG, and inertia sensors

Patients with dysphagia

perform motor function assessment by using scales, sEMG, and inertia sensors

perform motor function assessment by using scales, sEMG, and inertia sensors

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor function assessment
Time Frame: Change from Baseline scores at 1 month

Fugl-Meyer Assessment

Change from Baseline scores at 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surface EMG
Time Frame: Change from Baseline status at 1 month

high-density surface EMG

Change from Baseline status at 1 month
Kinematics test
Time Frame: Change from Baseline status at 1 month

Using inertia sensors to assess kinematics during movement

Change from Baseline status at 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: PX Wei, PhD, National Research Center for Rehabilitation Technical Aids

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2019

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

June 5, 2019

First Submitted That Met QC Criteria

June 6, 2019

First Posted (Actual)

June 7, 2019

Study Record Updates

Last Update Posted (Actual)

November 13, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe